AllovirInc Stock Valuation

ALVR
 Stock
  

USD 7.67  0.16  2.13%   

How much is AllovirInc worth today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as AllovirInc, is its stock price multiplied by the total number of shares outstanding, calculating AllovirInc's enterprise value requires a different approach. It uses AllovirInc's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
AllovirInc shows a prevailing Real Value of $15.79 per share. The current price of the firm is $7.67. At this time, the firm appears to be undervalued. Our model approximates the value of AllovirInc from analyzing the firm fundamentals such as Return On Equity of (0.72) %, current valuation of 441.38 M, and Shares Owned by Insiders of 49.88 % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor buying undervalued instruments and selling overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
  
AllovirInc Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as AllovirInc's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

AllovirInc Most Recent Valuation Data

Beta
0.63
change Receivables
400 K
Fiscal Year End
December
property Plant And Equipment Net
31.3 M
Enterprise Value
441.4 M
net Debt
35.8 M
Undervalued
Today 7.67
Please note that AllovirInc's price fluctuation is somewhat reliable at this time. Calculation of the real value of AllovirInc is based on 3 months time horizon. Increasing AllovirInc's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for AllovirInc is useful when determining the fair value of the AllovirInc stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of AllovirInc. Since AllovirInc is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AllovirInc Stock. However, AllovirInc's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
15.79
Real Value
21.19
Upside
Estimating the potential upside or downside of AllovirInc helps investors to forecast how AllovirInc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AllovirInc more accurately as focusing exclusively on AllovirInc's fundamentals will not take into account other important factors:
Earnings
Estimates (3)
LowProjected EPSHigh
-2.73-2.64-2.57
Details
Hype
Prediction
LowEstimated ValueHigh
1.617.0112.41
Details
Naive
Forecast
LowNext ValueHigh
1.396.8012.20
Details
4 Analysts
Consensus
LowTarget PriceHigh
32.0042.7555.00
Details

AllovirInc Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining AllovirInc's current stock value. Our valuation model uses many indicators to compare AllovirInc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AllovirInc competition to find correlations between indicators driving AllovirInc's intrinsic value. More Info.
AllovirInc is number one stock in net asset category among related companies. It is number one stock in beta category among related companies . The ratio of Net Asset to Beta for AllovirInc is about  457,306,526 . Comparative valuation analysis is a catch-all model that can be used if you cannot value AllovirInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AllovirInc's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AllovirInc's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AllovirInc's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AllovirInc and how it compares across the competition.

About AllovirInc Valuation

The stock valuation mechanism determines the current worth of AllovirInc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of AllovirInc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of AllovirInc based exclusively on its fundamental and basic technical indicators. By analyzing AllovirInc's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of AllovirInc's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of AllovirInc. We calculate exposure to AllovirInc's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to AllovirInc's related companies.
Fiscal Year End
December
Industry
Biotechnology
Concentration
Biotechnology
Full Time Employees
107.0
Service Category
Biotechnology
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell therapies to prevent and treat devastating viral-associated diseases. Allovir, Inc. was founded in 2013 and is based in Waltham, Massachusetts. Allovir operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 107 people.
Please continue to Trending Equities. You can also try Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Complementary Tools for analysis

When running AllovirInc price analysis, check to measure AllovirInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AllovirInc is operating at the current time. Most of AllovirInc's value examination focuses on studying past and present price action to predict the probability of AllovirInc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AllovirInc's price. Additionally, you may evaluate how the addition of AllovirInc to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Is AllovirInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AllovirInc. If investors know AllovirInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AllovirInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
668 M
Return On Assets
(0.38) 
Return On Equity
(0.72) 
The market value of AllovirInc is measured differently than its book value, which is the value of AllovirInc that is recorded on the company's balance sheet. Investors also form their own opinion of AllovirInc's value that differs from its market value or its book value, called intrinsic value, which is AllovirInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AllovirInc's market value can be influenced by many factors that don't directly affect AllovirInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AllovirInc's value and its price as these two are different measures arrived at by different means. Investors typically determine AllovirInc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AllovirInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.